Carillon Tower Advisers’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$39M Buy
217,206
+112,156
+107% +$24.9M 0.24% 130
2020
Q3
$23M Sell
105,050
-381,846
-78% -$85.2M 0.31% 108
2020
Q2
$109M Buy
486,896
+35,593
+8% +$5.58M 0.84% 21
2020
Q1
$44.1M Sell
451,303
-5,600
-1% -$453K 0.43% 68
2019
Q4
$34.3M Sell
456,903
-900
-0.2% -$58.1K 0.23% 154
2019
Q3
$28.1M Buy
457,803
+60,000
+15% +$3.61M 0.2% 181
2019
Q2
$23.6M Hold
397,803
0.16% 226
2019
Q1
$26M Hold
397,803
0.18% 201
2018
Q4
$19.4M Hold
397,803
0.16% 223
2018
Q3
$25.3M Buy
+397,803
New +$27.8M 0.18% 200

Other funds holding QDEL

Carillon Tower Advisers's QDEL Position: Q4 2020 in Review

Carillon Tower Advisers increased its QuidelOrtho (QDEL) stake by 107% in Q4 2020, buying an estimated $24.9M and bringing the position to 217,206 shares worth $39M. The position accounts for 0.24% of the portfolio, ranked #130.

Carillon Tower Advisers first reported a position in QDEL in Q3 2018 and has held it in 10 quarters since. The position peaked at $109M in Q2 2020. 387 funds tracked by Wall St. Rank hold QDEL as of Q4 2020.

  • Carillon Tower Advisers held 217,206 shares of QuidelOrtho worth $39M as of Q4 2020.
  • Carillon Tower Advisers bought 112,156 QuidelOrtho shares in Q4 2020, an estimated $24.9M.
  • QuidelOrtho made up 0.24% of Carillon Tower Advisers's portfolio in Q4 2020, its #130 holding.
  • Carillon Tower Advisers first reported a position in QuidelOrtho in Q3 2018 and has held it in 10 quarters since.
  • Carillon Tower Advisers's QuidelOrtho position peaked at $109M in Q2 2020.
  • 387 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.